File:Haloperidol.svg · Wikimedia Commons · See Wikimedia Commons
Haloperidol
Sign in to saveAlso known as Haloperidolum, Haldol®, MCN-JR-1625, R-1625, Serenace®, gamma-(4-(p-chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone, 4'-fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone, 4'-fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone
organische Verbindung, Arzneimittel, Neuroleptikum
OverviewAI-generated
Haloperidol is a chemical compound with the formula C₂₁H₂₃ClFNO₂. Its IUPAC name is 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one. The substance has a mass of 375.140135 and a weight of 375.9. It possesses a defined daily dose of 8.
Chemical properties include an xlogp of 3.2 and a topological polar surface area of 40.5. The molecule contains one hydrogen bond donor and four hydrogen bond acceptors, with a charge of 0. It is assigned the MCN code 2933.39.15.
In scientific literature, haloperidol is the subject of 24,000 PubMed entries. The compound is referenced by 3,093 other encyclopedia articles.
Synthesized by Vinony from 19 facts across 4 sources: Wikidata, PubMed, PubChem, Vinony graph. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
Key facts
- Drug.KEGG
- D00136
- Drug.ChEBI
- 5613
- Drug.ChEMBL
- 54
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 464369120
- Drug.image
- Haloperidol.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 250px
- Drug.image2
- Haloperidol-from-xtal-3D-balls.png
- Drug.image_class2
- bg-transparent
- Drug.width2
- 250px
- Drug.tradename
- Haldol, others
- Drug.MedlinePlus
- a682180
- Drug.DailyMedID
- Haloperidol
- Drug.pregnancy_AU
- C
- Drug.routes_of_administration
- By mouth, intramuscular, intravenous, depot (as decanoate ester)
- Drug.class
- Typical antipsychotic
- Drug.ATC_prefix
- N05
via Wikipedia infobox
Chemical data
- Formula
- C21H23ClFNO2
- Molecular weight
- 375.9 g/mol
- IUPAC name
- 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one
- SMILES
- C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
- InChIKey
- LNEPOXFFQSENCJ-UHFFFAOYSA-N
- XLogP
- 3.2
- Polar surface area
- 40.5 Ų
- H-bond donors
- 1
- H-bond acceptors
- 4
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 1967
- Admin. routes
- oral, parenteral
- Indications
- psychosis, post-operative sign or symptom, Tourette syndrome, conduct disorder
via ChEMBL · EBI
Research
24,000 papersvia PubMed
Wikidata facts
- Subclass of
- heterocyclic compound
- Has part
- chlorine
- Mass
- 375.140135
- Has use
- medication
Show 12 more facts
- Commons category
- Haloperidol
- significant drug interaction
- olanzapine
- chemical formula
- C₂₁H₂₃ClFNO₂
- MCN code
- 2933.39.15
- medical condition treated
- delirium
- defined daily dose
- 8
- canonical SMILES
- C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
- World Health Organisation international non-proprietary name
- haloperidol
- subject has role
- essential medicine
- physically interacts with
- Dopamine receptor D3
- has characteristic
- bitterness
- legal status (medicine)
- boxed warning
Sources (10)
via Wikidata · CC0
Article · Deutsch
Haloperidol ist ein hochpotentes Neuroleptikum aus der Gruppe der Butyrophenone und wird unter anderem zur Behandlung akuter und chronischer schizophrener Syndrome und bei akuten psychomotorischen Erregungszuständen eingesetzt.
Abstract from DBpedia / Wikipedia · CC BY-SA